Gregory Piazza: Proud Moment for Thrombosis Research Group at ACC.26
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“So proud of our Thrombosis Research Group fellows, Sina and Mariana, who had numerous presentations at ACC.26 including one analyzing our HI-PRO RCT with simultaneous publication in JAMA Cardiology!!
In awe of these guys!!
I was definitely not as productive as they have been when I was at their stage!”
Title: Extended Low-Dose Apixaban and Superficial Vein Thrombosis
Authors: Sina Rashedi, Mariana Pfeferman, Arvind Pandey, Darsiya Krishnathasan, Candrika D Khairani, Antoine Bejjani, Ruth H Morrison, Heather Hogan, Junyang Lou, John Fanikos, Nicole Porio, Lisa Rosenbaum, Piotr S Sobieszczyk, Zhou Lan, Marie Gerhard-Herman, Umberto Campia, Samuel Z Goldhaber, Behnood Bikdeli, Gregory Piazza
Read the Full Article on JAMA Cardiology
Other posts featuring Gregory Piazza on Hemsotasis Today.
-
Apr 1, 2026, 15:31Simon Senanu: A Stepwise Laboratory Approach for aPTT Prolongation
-
Apr 1, 2026, 15:30Liza Bulsara: Early Clinical Warning Signs of Pediatric Hematologic Disorders
-
Apr 1, 2026, 15:10Nathan Connel: How Policy Changes Redefine Medical Care
-
Apr 1, 2026, 14:58Steve Cleveland: Tumor-Educated Platelets as a Platform for Early Cancer Detection
-
Apr 1, 2026, 14:53Hayley Emma Arron: Supporting Future Strategies for Venous Thrombosis in Spaceflight and Exploration
-
Apr 1, 2026, 14:44Chad Mineo: Platelet-Rich Plasma as an Adjunct to Rehabilitation in Grade 2 Hamstring Injuries
-
Apr 1, 2026, 14:41How Psychosocial Care Transforms Fear into Clarity and Stability – WFH
-
Apr 1, 2026, 14:23Ingo Ahrens: When Bleeding Poses a Greater Risk Than Ischemia
-
Apr 1, 2026, 13:48Anas Ibraheem: Apixaban Shows Superior Safety in Acute VTE While Matching Rivaroxaban Efficacy